This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Eri Tokumaru: Innovator in Pharmaceutical Chemistry
Introduction
Eri Tokumaru is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential. With a total of 3 patents, her work is recognized for its innovative approach to addressing complex biological interactions.
Latest Patents
Eri Tokumaru's latest patents include a Cycloalkane-1,3-diamine derivative. This invention provides a compound or a pharmaceutically acceptable salt that exhibits an inhibitory action on the interaction between menin and an MLL protein. The compound is represented by a specific formula, where various components are defined in detail within the patent description. This innovative approach has the potential to impact therapeutic strategies significantly.
Career Highlights
Eri Tokumaru is currently employed at Daiichi Sankyo Company, Limited, where she continues to advance her research in pharmaceutical development. Her work is characterized by a commitment to innovation and excellence in the field.
Collaborations
Throughout her career, Eri has collaborated with esteemed colleagues, including Kenji Yoshikawa and Noriyasu Haginoya. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Eri Tokumaru stands out as a pioneering inventor in the pharmaceutical industry. Her contributions, particularly in the development of novel compounds, highlight her dedication to advancing medical science. Her work continues to inspire future innovations in the field.